This project defines the responses of cells to DNA and RNA damaging agents. The work relates the structures of specific types of nucleic acid damage with the mutations those lesions produce in vivo. Two key features of the project are (1) its emphasis on in vivo analysis of the biology of DNA adducts, many of which are produced by human carcinogens and (2) the emphasis on rigorous synthetic methodology for preparation of adduct containing oligonucleotides and genomes. The work on the path ahead will divide into the following areas, which are a continuation ofthe theme established during the first four years of support. Our first goal, will be to continue to develop methodology for synthesis of DNA oligonucleotides containing specific modified bases at defined sites. The work proposed requires synthesis of oligonucleotides containing 5-substituted cytosines (produced by oxidative stress), a series of N and 0-alkylated purines and pyrimidines (produced by alkylation and inflammation), and N2 and C8-purine aromatic amine adducts (produed by tobacco smoke). In addition, we are preparing oligonucleotides containing a {guanine Nl-ethyl- N3 cytosine} interstrand crosslink and the DNA adducts of the liver carcinogen, aflatoxin 81. Our second goal is to continue the Biological evaluation of damaged DNA bases in vivo. Genomes of viruses and plasmids will be re-engineered to contain gaps (e.g., 16 nucleotides) at specific sites. The modified oligonucleotides will be insert:ed by ligation into the gaps, forming a site-specifically modified genome. To study mutation and lethality, the genomes containing defined lesions will be introduced into cells, and progeny will be isolated, enumerated to determine toxicity, and sequenced to determine mutation. Our third goal is to establish a system that permits the study of RNA lesion replication and repair in vivo. It is logical to assume that cells have a repair system to address the need to remove damage from RNA, and our methodology lends itself well to answer that question. Finally, we are adapting our mutation-analysis technology to probe mutational mechanisms of adducts replicated intrachromosomally in mammalian cells.

Public Health Relevance

This project defines the type, amount and genetic requirements for mutagenesis by carcinogens. It defines the eariy, chemical, steps in the conversion of normal cells into cancer cells. Moreover, the project helps identify the pathways by which cells defend against cancer-causing DNA damage. From the public health perspective, the adducts studied here are candidate biomarkers that could be used to gauge cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA080024-16
Application #
8298319
Study Section
Special Emphasis Panel (NSS)
Program Officer
Okano, Paul
Project Start
1998-07-01
Project End
2016-02-28
Budget Start
2013-04-25
Budget End
2014-02-28
Support Year
16
Fiscal Year
2013
Total Cost
$367,311
Indirect Cost
$124,811
Name
Massachusetts Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Li, Deyu; Fedeles, Bogdan I; Singh, Vipender et al. (2014) Tautomerism provides a molecular explanation for the mutagenic properties of the anti-HIV nucleoside 5-aza-5,6-dihydro-2'-deoxycytidine. Proc Natl Acad Sci U S A 111:E3252-9
Shrivastav, Nidhi; Fedeles, Bogdan I; Li, Deyu et al. (2014) A chemical genetics analysis of the roles of bypass polymerase DinB and DNA repair protein AlkB in processing N2-alkylguanine lesions in vivo. PLoS One 9:e94716
Singh, Vipender; Peng, Chunte Sam; Li, Deyu et al. (2014) Direct observation of multiple tautomers of oxythiamine and their recognition by the thiamine pyrophosphate riboswitch. ACS Chem Biol 9:227-36
Li, Deyu; Fedeles, Bogdan I; Shrivastav, Nidhi et al. (2013) Removal of N-alkyl modifications from N(2)-alkylguanine and N(4)-alkylcytosine in DNA by the adaptive response protein AlkB. Chem Res Toxicol 26:1182-7
Rechkoblit, Olga; Delaney, James C; Essigmann, John M et al. (2011) Implications for damage recognition during Dpo4-mediated mutagenic bypass of m1G and m3C lesions. Structure 19:821-32
Shrivastav, Nidhi; Li, Deyu; Essigmann, John M (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31:59-70
Jarosz, Daniel F; Cohen, Susan E; Delaney, James C et al. (2009) A DinB variant reveals diverse physiological consequences of incomplete TLS extension by a Y-family DNA polymerase. Proc Natl Acad Sci U S A 106:21137-42
Lee, Chun-Yue I; Delaney, James C; Kartalou, Maria et al. (2009) Recognition and processing of a new repertoire of DNA substrates by human 3-methyladenine DNA glycosylase (AAG). Biochemistry 48:1850-61
Mundle, Sophia T; Delaney, James C; Essigmann, John M et al. (2009) Enzymatic mechanism of human apurinic/apyrimidinic endonuclease against a THF AP site model substrate. Biochemistry 48:19-26
Delaney, James C; Gao, Jianmin; Liu, Haibo et al. (2009) Efficient replication bypass of size-expanded DNA base pairs in bacterial cells. Angew Chem Int Ed Engl 48:4524-7